Literature DB >> 30985215

Design of Idiopathic Pulmonary Fibrosis Clinical Trials in the Era of Approved Therapies.

Robert J Kaner1,2, Ednan K Bajwa3, Moustapha El-Amine4, Eduard Gorina5, Renu Gupta6, Howard M Lazarus7, Tracy R Luckhardt8, Majd Mouded9, Kaity Posada10, Luca Richeldi11, John Stauffer12, Ahmet Tutuncu13, Fernando J Martinez1.   

Abstract

Entities:  

Year:  2019        PMID: 30985215     DOI: 10.1164/rccm.201903-0592PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  1 in total

1.  Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?

Authors:  Nada Taha; Dejanira D'Amato; Karishma Hosein; Tiziana Ranalli; Gianluigi Sergiacomi; Maurizio Zompatori; Marco Mura
Journal:  Respir Res       Date:  2020-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.